GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF-<i>κ</i>B Signaling Pathways

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Gene</td><td class="align_center">Forward</td><td class="align_center">Reverse</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left"><i>Gapdh</i></td><td class="align_center">ACCCAGAAGACTGTGGATGG</td><td class="align_center">CACATTGGGGGTAGGAACAC</td></tr><tr><td class="align_left"><i>Tnf</i></td><td class="align_center">GCCTCTTCTCATTCCTGCTTGTGG</td><td class="align_center">GTGGTTTGTGAGTGTGAGGGTCTG</td></tr><tr><td class="align_left"><i>Il1b</i></td><td class="align_center">TCGCAGCAGCACATCAACAAGAG</td><td class="align_center">AGGTCCACGGGAAAGACACAGG</td></tr><tr><td class="align_left"><i>Il6</i></td><td class="align_center">CTTCTTGGGACTGATGCTGGTGAC</td><td class="align_center">AGGTCTGTTGGGAGTGGTATCCTC</td></tr><tr><td class="align_left"><i>Nos2</i></td><td class="align_center">ACTCAGCCAAGCCCTCACCTAC</td><td class="align_center">TCCAATCTCTGCCTATCCGTCTCG</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Oxidative Medicine and Cellular Longevity

tab1

Table 1

Table 1: GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF-<i>κ</i>B Signaling Pathways 

Oxidative Medicine and Cellular Longevity

GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF-κB Signaling Pathways

Table 1